Sinovac Applies for Conditional Approval of Covid-19 Vaccine in China
China's medicine regulator is reviewing a second domestically developed Covid-19 vaccine for conditional approval. The CoronaVac inoculation developed by Sinovac Biotech Ltd has been given to tens of thousands of people in China under an emergency use programme launched in July targeting specific groups with high infection risks.
View the full story here: https://www.caixinglobal.com/2021-02-04/sinovac-applies-for-conditional-approval-of-covid-19-vaccine-in-china-101660120.html